HIV market will see modest growth to $22.5 billion by 2025, report

The human immunodeficiency virus (HIV) market across the nine major countries of the USA, France, Germany, Italy, Spain, the UK, Japan, Brazil, and China, is set to grow from $16.3 billion in 2015 to $22.5 billion by 2025, representing a compound annual growth rate of just over 3%.

According to research and consulting firm GlobalData’s latest report, this relatively modest growth will mainly be driven by the introduction of novel drugs, an increasing number of people living with HIV who are treated with antiretroviral therapy (ART), and increased efforts to identify new infections through aggressive screening and diagnostic policies. The adoption of the test-and-treat approach to increase the number of patients on ART and reduce viral loads will also be a factor.

Unmet needs